Comparison Study of Two Differently Clicked 18F-Folates-Lipophilicity Plays a Key Role
- PMID: 29562610
- PMCID: PMC5874726
- DOI: 10.3390/ph11010030
Comparison Study of Two Differently Clicked 18F-Folates-Lipophilicity Plays a Key Role
Abstract
Within the last decade, several folate-based radiopharmaceuticals for Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) have been evaluated; however, there is still a lack of suitable 18F-folates for clinical PET imaging. Herein, we report the synthesis and evaluation of two novel 18F-folates employing strain-promoted and copper-catalyzed click chemistry. Furthermore, the influence of both click-methods on lipophilicity and pharmacokinetics of the 18F-folates was investigated. 18F-Ala-folate and 18F-DBCO-folate were both stable in human serum albumin. In vitro studies proved their high affinity to the folate receptor (FR). The lipophilic character of the strain-promoted clicked 18F-DBCO-folate (logD = 0.6) contributed to a higher non-specific binding in cell internalization studies. In the following in vivo PET imaging studies, FR-positive tumors could not be visualized in a maximum intensity projection images. Compared with 18F-DBCO-folate, 18F-Ala-folate (logD = -1.4), synthesized by the copper-catalyzed click reaction, exhibited reduced lipophilicity, and as a result an improved in vivo performance and a clear-cut visualization of FR-positive tumors. In view of high radiochemical yield, radiochemical purity and favorable pharmacokinetics, 18F-Ala-folate is expected to be a promising candidate for FR-PET imaging.
Keywords: 18F-folates; PET; click chemistry; copper-catalyzed click; folate receptor; folic acid; strain promoted click.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.Bioconjug Chem. 2008 Dec;19(12):2462-70. doi: 10.1021/bc800356r. Bioconjug Chem. 2008. PMID: 19053298
-
18 F-click labeling and preclinical evaluation of a new 18 F-folate for PET imaging.EJNMMI Res. 2013 Sep 16;3(1):68. doi: 10.1186/2191-219X-3-68. EJNMMI Res. 2013. PMID: 24041035 Free PMC article.
-
Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.Mol Pharm. 2016 May 2;13(5):1520-7. doi: 10.1021/acs.molpharmaceut.5b00989. Epub 2016 Apr 18. Mol Pharm. 2016. PMID: 27054811 Free PMC article.
-
(18) F-labeled folic acid derivatives for imaging of the folate receptor via positron emission tomography.J Labelled Comp Radiopharm. 2013 Jul-Aug;56(9-10):432-40. doi: 10.1002/jlcr.3104. J Labelled Comp Radiopharm. 2013. PMID: 24285516 Review.
-
2-[(4-{[(2-amino-4-oxohydropteridin-7yl)methyl]amino}phenyl) carbonylamino]-4-{N-[(2-[18F]-fluoro(4-pyridyl))carbonylamino] carbamoyl}butanoic acid.2011 Nov 16 [updated 2011 Dec 26]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2011 Nov 16 [updated 2011 Dec 26]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 22238794 Free Books & Documents. Review.
Cited by
-
eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumors.EJNMMI Radiopharm Chem. 2024 May 22;9(1):44. doi: 10.1186/s41181-024-00272-0. EJNMMI Radiopharm Chem. 2024. PMID: 38775990 Free PMC article.
-
Development of Folate Receptor-Targeted PET Radiopharmaceuticals for Tumor Imaging-A Bench-to-Bedside Journey.Cancers (Basel). 2020 Jun 9;12(6):1508. doi: 10.3390/cancers12061508. Cancers (Basel). 2020. PMID: 32527010 Free PMC article. Review.
-
Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.Front Med (Lausanne). 2022 Jun 6;9:902155. doi: 10.3389/fmed.2022.902155. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35733858 Free PMC article. Review.
-
2-Deoxyglucose-Modified Folate Derivative: Self-Assembling Nanoparticle Able to Load Cisplatin.Molecules. 2019 Mar 19;24(6):1084. doi: 10.3390/molecules24061084. Molecules. 2019. PMID: 30893851 Free PMC article.
-
Radiopharmaceutical therapy in cancer: clinical advances and challenges.Nat Rev Drug Discov. 2020 Sep;19(9):589-608. doi: 10.1038/s41573-020-0073-9. Epub 2020 Jul 29. Nat Rev Drug Discov. 2020. PMID: 32728208 Free PMC article. Review.
References
-
- Whetstine J.R., Flatley R.M., Matherly L.H. The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: Identification of seven non-coding exons and characterization of a novel promoter. Biochem. J. 2002;367:629–640. doi: 10.1042/bj20020512. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources